|
"yeh kh"的相關文件
顯示項目 1-25 / 108 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2023-05-24 |
Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
|
Yoshino, T;Cervantes, A;Bando, H;Martinelli, E;Oki, E;Xu, RH;Mulansari, NA;Govind Babu, K;Lee, MA;Tan, CK;Cornelio, G;Chong, DQ;Chen, LT;Tanasanvimon, S;Prasongsook, N;Yeh, KH;Chua, C;Sacdalan, MD;Sow Jenson, WJ;Kim, ST;Chacko, RT;Syaiful, RA;Zhang, SZ;Curigliano, G;Mishima, S;Nakamura, Y;Ebi, H;Sunakawa, Y;Takahashi, M;Baba, E;Peters, S;Ishioka, C;Pentheroudakis, G |
| 臺大學術典藏 |
2022-05-30T02:36:16Z |
On Privacy Aware Carriers for Value-Possessed e-Invoices Considering Intelligence Mining
|
Cha, SC; Wang, H; Tan, ZY; YUH-JZER JOUNG; Tseng, YC; Yeh, KH |
| 國家衛生研究院 |
2022-02-16 |
Current status of the spectrum and therapeutics of helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Lin, CW;Liou, JM;Wu, MS;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2021-09-04 |
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: Post hoc subanalysis from the ATTRACTION-2 study
|
Kang, YK;Morita, S;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Sameshima, H;Chen, LT;Boku, N |
| 國家衛生研究院 |
2021-03-20 |
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
|
Boku, N;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Nishiyama, T;Chen, LT;Kang, YK |
| 國家衛生研究院 |
2020-04-06 |
JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
|
Yoshino, T;Pentheroudakis, G;Mishima, S;Overman, MJ;Yeh, KH;Baba, E;Naito, Y;Calvo, F;Saxena, A;Chen, LT;Takeda, M;Cervantes, A;Taniguchi, H;Yoshida, K;Kodera, Y;Kitagawa, Y;Tabernero, J;Burris, H;Douillard, JY |
| 中山醫學大學 |
2020 |
Observational study of dronedarone in Taiwanese patients with atrial fibrillation
|
Lin, JL; Wu, TJ; Chen, CP; Hsu, JC; Ueng, KC; Kuo, JY; Chen, MC; Yeh, KH; Chang, KC; Lu, YY; Shyu, KG; Wen, MS; Chen, SA; Hsieh, MH; Tseng, WK; Feng, AN; Yang, TY; Ko, WC; Cheng, CW; Liu, JC; Lai, WT |
| 國家衛生研究院 |
2019-12-20 |
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
|
Chen, LT;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Sameshima, H;Kang, YK;Boku, N |
| 國家衛生研究院 |
2019-11-14 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai, HJ;Tai, JJ;Chen, LT;Wu, MS;Yeh, KH;Lin, CW;Wang, TE;Wang, HP;Yu, FJ;Liou, JM;Hsiao, CF;Cheng, TY;Yeh, HJ;Ko, CW;Chen, MJ;Lo, GH;Hsu, PI;Chang, CS;Hwang, WS;Chuang, SS;Lee, HW;Shun, CT;Chiu, CF;Wang, WM;Hsieh, CY;Liu, TW;Lin, JT;Kuo, SH;Cheng, AL |
| 國家衛生研究院 |
2019-05-13 |
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: A randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
|
Satoh, T;Kang, YK;Chao, Y;Ryu, MH;Kato, K;Cheol Chung, H;Chen, JS;Muro, K;Ki Kang, W;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Tanimoto, M;Chen, LT;Boku, N |
| 國家衛生研究院 |
2019-04-17 |
Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Wu, MS;Yeh, KH;Lin, CW;Hsu, PN;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2018-11-22 |
Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic gastric cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
|
Muro, K;Van Cutsem, E;Narita, Y;Pentheroudakis, G;Baba, E;Li, J;Ryu, MH;Zamaniah, WIW;Yong, WP;Yeh, KH;Kato, K;Lu, Z;Cho, BC;Nor, IM;Ng, M;Chen, LT;Nakajima, TE;Shitara, K;Kawakami, H;Tsushima, T;Yoshino, T;Lordick, F;Martinelli, E;Smyth, EC;Arnold, D;Minami, H;Tabernero, J;Douillard, JY |
| 國家衛生研究院 |
2018-11-22 |
Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic oesophageal cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
|
Muro, K;Lordick, F;Tsushima, T;Pentheroudakis, G;Baba, E;Lu, Z;Cho, BC;Nor, IM;Ng, M;Chen, LT;Kato, K;Li, J;Ryu, MH;Zamaniah, WIW;Yong, WP;Yeh, KH;Nakajima, TE;Shitara, K;Kawakami, H;Narita, Y;Yoshino, T;Van Cutsem, E;Martinelli, E;Smyth, EC;Arnold, D;Minami, H;Tabernero, J;Douillard, JY |
| 國家衛生研究院 |
2018-01 |
Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma
|
Javle, M;Lowery, M;Shroff, RT;Weiss, KH;Springfeld, C;Borad, MJ;Ramanathan, RK;Goyal, L;Sadeghi, S;Macarulla, T;El-Khoueiry, A;Kelley, RK;Borbath, I;Choo, SP;Oh, DY;Philip, PA;Chen, LT;Reungwetwattana, T;Van Cutsem, E;Yeh, KH;Ciombor, K;Finn, RS;Patel, A;Sen, S;Porter, D;Isaacs, R;Zhu, AX;Abou-Alfa, GK;Bekaii-Saab, T |
| 國家衛生研究院 |
2017-12 |
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Kang, YK;Boku, N;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Chen, LT |
| 國家衛生研究院 |
2017-11-16 |
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer; A JSMO - ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
|
Yoshino, T;Arnold, D;Taniguchi, H;Pentheroudakis, G;Yamazaki, K;Xu, RH;Kim, TW;Ismail, F;Tan, IB;Yeh, KH;Grothey, A;Zhang, S;Ahn, JB;Chong, D;Chen, LT;Kopetz, S;Eguchi-Nakajima, T;Ebi, H;Ohtsu, A;Cervantes, A;Muro, K;Tabernero, J;Minami, H;Ciardiello, F;Douillard, JY |
| 國家衛生研究院 |
2017-10 |
Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review
|
Chen, LT;Oh, DY;Ryu, MH;Yeh, KH;Yeo, W;Carlesi, R;Cheng, R;Kim, J;Orlando, M;Kang, YK |
| 國家衛生研究院 |
2017-10 |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Wu, MS;Lin, CW;Wei, MF;Liou, JM;Wang, HP;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2017-02 |
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)
|
Kuo, SH;Tsai, HJ;Lin, CW;Yeh, KH;Lee, HW;Wei, MF;Shun, CT;Wu, MS;Hsu, PN;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2017-01 |
Expressions of the CagA protein and CagA-signaling molecules predict H. pylori-dependence of early-stage gastric DLBCL
|
Kuo, SH;Chen, LT;Lin, CW;Yeh, KH;Shun, CT;Tzeng, YS;Liou, JM;Wu, MS;Hsu, PN;Cheng, AL |
| 國家衛生研究院 |
2016-10 |
CagA and NFAT co-operatively participate in the lymphomagenesis of gastric MALT lymphoma
|
Kuo, SH;Tsai, HJ;Yeh, KH;Lin, CW;Zeng, YS;Wu, MS;Hsu, PN;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2016-05 |
Efficacy of frontline antibiotics therapy in the treatment of Helicobacter pylori-negative gastric low-grade mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Wu, MS;Lin, CW;Tsai, HJ;Wei, MF;Lee, HW;Liou, JM;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2016-02 |
Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy
|
Chiang, NJ;Yeh, KH;Chiu, CF;Chen, JS;Yen, CC;Lee, KD;Lin, YL;Bai, LY;Chen, MH;Lin, JS;Yang, Y;Rau, KM;Hsiao, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2015-09 |
Expression of the Helicobater pylori CagA protein is closely associated with Helicobater pylori-dependence of early-stage high-grade gastric lymphoma
|
Kuo, SH;Chen, LT;Lin, CW;Yeh, KH;Tsai, HJ;Tzeng, YS;Wu, MS;Hsu, PN;Cheng, AL |
| 國家衛生研究院 |
2015-06 |
Helicobacter pylori CagA translocation is closely associated with the expression of CagA-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Chen, LT;Lin, CW;Hsu, PN;Wu, MS;Liou, JM;Tsai, HJ;Tzeng, YS;Cheng, AL |
顯示項目 1-25 / 108 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
